These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Subcutaneous heparin treatment]. Robertson B Nord Med; 1965 Oct; 74(40):994-7. PubMed ID: 5836667 [No Abstract] [Full Text] [Related]
7. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin. Monreal M; Lafoz E; Olive A; del Rio L; Vedia C Thromb Haemost; 1994 Jan; 71(1):7-11. PubMed ID: 8165649 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population. Ugaki H; Enomoto T; Fujiwara K; Kimura T; Kawasaki T Blood Coagul Fibrinolysis; 2008 Sep; 19(6):585-9. PubMed ID: 18685443 [TBL] [Abstract][Full Text] [Related]
11. Effects of heparin therapy on fibrinolysis in patients with pulmonary embolism. Minnema MC; ten Cate H; van Beek EJ; van den Ende A; Hack CE; Brandjes DP Thromb Haemost; 1997 Jun; 77(6):1164-7. PubMed ID: 9241751 [TBL] [Abstract][Full Text] [Related]
12. [Incidence of pulmonary embolism at our clinic following introduction of heparin therapy by small subcutaneous doses]. Erdi A; Baranyai L Orv Hetil; 1978 Feb; 119(7):395-7. PubMed ID: 625413 [No Abstract] [Full Text] [Related]
13. Subcutaneous low-molecular-weight heparin fragmin versus intravenous unfractionated heparin in the treatment of acute non massive pulmonary embolism: an open randomized pilot study. Meyer G; Brenot F; Pacouret G; Simonneau G; Gillet Juvin K; Charbonnier B; Sors H Thromb Haemost; 1995 Dec; 74(6):1432-5. PubMed ID: 8772215 [TBL] [Abstract][Full Text] [Related]
14. Low molecular weight heparin (dalteparin) is equally effective as unfractionated heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism. Schutgens RE; Esseboom EU; Snijder RJ; Haas FJ; Verzijlbergen F; Nieuwenhuis HK; Lisman T; Biesma DH J Lab Clin Med; 2004 Aug; 144(2):100-7. PubMed ID: 15322504 [TBL] [Abstract][Full Text] [Related]
15. Tinzaparin: new indication. Easier treatment of less severe pulmonary embolism. Prescrire Int; 2002 Feb; 11(57):13-5. PubMed ID: 11985368 [TBL] [Abstract][Full Text] [Related]
16. [Low dosage of heparin. Theoretical and practical evaluation]. Gormsen J; Feddersen C; Clausen NT Ugeskr Laeger; 1974 Apr; 136(16):865-70. PubMed ID: 4825561 [No Abstract] [Full Text] [Related]
17. Subcutaneous heparin for prophylaxis of venous thromboembolism in deep brain stimulation surgery: evidence from a decision analysis. Bauman JA; Church E; Halpern CH; Danish SF; Zaghloul KA; Jaggi JL; Stein SC; Baltuch GH Neurosurgery; 2009 Aug; 65(2):276-80; discussion 280. PubMed ID: 19625905 [TBL] [Abstract][Full Text] [Related]
18. [The diagnosis, treatment and prevention of thromboembolism of the pulmonary artery in a general hospital]. Ukolov VM; Rakov AL; Krashutskiĭ VV; Proskurin VM; Shepilov VV Voen Med Zh; 1995 Oct; (10):34-8. PubMed ID: 8533359 [No Abstract] [Full Text] [Related]
19. [Clinical effect of subcutaneous low-dose heparin]. Andrassy T; Mayer W; Walz B Med Welt; 1981 May; 32(19):735-7. PubMed ID: 7231136 [No Abstract] [Full Text] [Related]
20. [Strategies for utilization of anticoagulants in pulmonary embolism]. Fartoukh M; Simonneau G Rev Mal Respir; 1999 Nov; 16(5 Pt 2):949-60. PubMed ID: 10907444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]